-
-
-
-
-
-
-
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Cabaletta Bio, Inc. (CABA) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
Cabaletta Bio (CABA) Announces $35 Million Offering of Common Stock, Warrants
-
-
-
-
-
-
-
Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Affirm, Cabaletta, Ericsson, and C3.ai and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Affirm and Cabaletta and Encourages Investors to Contact the Firm
-
1,222,611 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

